Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
Abstract Background Sodium–glucose cotransporter-2(SGLT-2) inhibitors are a newer class of antidiabetic drugs with the increased risk of euglycemic diabetic ketoacidosis(EuDKA). Encephalopathy is a rare but life-threatening event of EuDKA. Due to paradoxically normal or slightly elevated serum gluco...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04027-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594634911514624 |
|---|---|
| author | Lulu Chu Zhenhua Xi Runzhi Ma Weiliang Shi Guoshen Yu |
| author_facet | Lulu Chu Zhenhua Xi Runzhi Ma Weiliang Shi Guoshen Yu |
| author_sort | Lulu Chu |
| collection | DOAJ |
| description | Abstract Background Sodium–glucose cotransporter-2(SGLT-2) inhibitors are a newer class of antidiabetic drugs with the increased risk of euglycemic diabetic ketoacidosis(EuDKA). Encephalopathy is a rare but life-threatening event of EuDKA. Due to paradoxically normal or slightly elevated serum glucose levels, it’s easy to be mimicked by cerebral infarction, structural brain damage, thus leading to delayed diagnosis and causing seriously irreversible brain injury. Case presentation We report severe EuDKA with metabolic encephalopathy secondary to dapagliflozin in a type 2 diabetes mellitus(T2DM) patient.A 72-year-old female was found unconscious 70 minutes ago.Laboratory evaluation revealed a severe metabolic acidosis with an elevated anion gap, and ketones were elevated in the blood and positive in the urine. The patient was eventually diagnosed with metabolic encephalopathy associated with EuDKA and managed accordingly. Conclusions Metabolic encephalopathy is a rare but life-threatening complication of EuDKA caused by SGLT-2 inhibitors, the imaging features are similar to those of other metabolic encephalopathy such as poisoning and hypoxia. The precise pathogenesis of encephalopathy in EuDKA remains poorly understood, potentially resulting from the toxic consequences of electrolyte disturbances, ketosis, and acidosis.Testing the level of ketones is essential for unconscious patients who are taking SGLT-2 inhibitors. |
| format | Article |
| id | doaj-art-92674e4729e44a139961cd8279358f7c |
| institution | Kabale University |
| issn | 1471-2377 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Neurology |
| spelling | doaj-art-92674e4729e44a139961cd8279358f7c2025-01-19T12:28:05ZengBMCBMC Neurology1471-23772025-01-012511510.1186/s12883-025-04027-5Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case reportLulu Chu0Zhenhua Xi1Runzhi Ma2Weiliang Shi3Guoshen Yu4Department of Neurology, Haiyan People’s HospitalDepartment of Neurology, Haiyan People’s HospitalDepartment of Neurology, Haiyan People’s HospitalDepartment of Neurology, Haiyan People’s HospitalDepartment of Neurology, Haiyan People’s HospitalAbstract Background Sodium–glucose cotransporter-2(SGLT-2) inhibitors are a newer class of antidiabetic drugs with the increased risk of euglycemic diabetic ketoacidosis(EuDKA). Encephalopathy is a rare but life-threatening event of EuDKA. Due to paradoxically normal or slightly elevated serum glucose levels, it’s easy to be mimicked by cerebral infarction, structural brain damage, thus leading to delayed diagnosis and causing seriously irreversible brain injury. Case presentation We report severe EuDKA with metabolic encephalopathy secondary to dapagliflozin in a type 2 diabetes mellitus(T2DM) patient.A 72-year-old female was found unconscious 70 minutes ago.Laboratory evaluation revealed a severe metabolic acidosis with an elevated anion gap, and ketones were elevated in the blood and positive in the urine. The patient was eventually diagnosed with metabolic encephalopathy associated with EuDKA and managed accordingly. Conclusions Metabolic encephalopathy is a rare but life-threatening complication of EuDKA caused by SGLT-2 inhibitors, the imaging features are similar to those of other metabolic encephalopathy such as poisoning and hypoxia. The precise pathogenesis of encephalopathy in EuDKA remains poorly understood, potentially resulting from the toxic consequences of electrolyte disturbances, ketosis, and acidosis.Testing the level of ketones is essential for unconscious patients who are taking SGLT-2 inhibitors.https://doi.org/10.1186/s12883-025-04027-5DapagliflozinEuglycemic diabetic ketoacidosisMetabolic encephalopathySodium–glucose cotransporter-2 inhibitorsCase report |
| spellingShingle | Lulu Chu Zhenhua Xi Runzhi Ma Weiliang Shi Guoshen Yu Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report BMC Neurology Dapagliflozin Euglycemic diabetic ketoacidosis Metabolic encephalopathy Sodium–glucose cotransporter-2 inhibitors Case report |
| title | Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report |
| title_full | Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report |
| title_fullStr | Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report |
| title_full_unstemmed | Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report |
| title_short | Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report |
| title_sort | euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin a rare case report |
| topic | Dapagliflozin Euglycemic diabetic ketoacidosis Metabolic encephalopathy Sodium–glucose cotransporter-2 inhibitors Case report |
| url | https://doi.org/10.1186/s12883-025-04027-5 |
| work_keys_str_mv | AT luluchu euglycemicdiabeticketoacidosisassociatedmetabolicencephalopathycausedbydapagliflozinararecasereport AT zhenhuaxi euglycemicdiabeticketoacidosisassociatedmetabolicencephalopathycausedbydapagliflozinararecasereport AT runzhima euglycemicdiabeticketoacidosisassociatedmetabolicencephalopathycausedbydapagliflozinararecasereport AT weiliangshi euglycemicdiabeticketoacidosisassociatedmetabolicencephalopathycausedbydapagliflozinararecasereport AT guoshenyu euglycemicdiabeticketoacidosisassociatedmetabolicencephalopathycausedbydapagliflozinararecasereport |